Complementary
NAFDAC explains position on claims for coronavirus remedies
The National Agency for Food and Drug Administration and Control (NAFDAC) has said that the rush to mitigate the mortality and morbidly resulting from the COVID-19 pandemic has resulted in acceleration of product development, repurposing of formulations, off label use of therapeutics and the search for a vaccine to prevent COVID-19. The agency however noted that it has only received application from one company for a product the company is presenting (for approval) to the Agency for the treatment of the symptoms of Covid-19, and not for the cure of Covid-19 as a disease. In a statement yesterday in Abuja, Director General of NAFDAC, Prof Mojisola Christianah Adeyeye stated that in a bid to discover a cure for Covid-19 disease, the public has witnessed quite a number of claims from differen...
PTF: NAFDAC screening local cures for coronavirus
The Federal Government said yesterday it has evaluated claims by local researchers that they have manufactured curative drugs for COVID-19. It explained that having met preliminary requirements, the drugs had been forwarded to the National Agency for Food and Drug Administration and Control, NAFDAC, for listing. National Coordinator of the Presidential Task Force for COVID-19, Dr. Sani Aliyu, had restated the federal government’s position on Wednesday that no cure had been found for the disease. The government also expressed worries over the continued repatriation of Almajiriai by states, saying the development could fuel a spike in infections. On compliance with general safety protocols put in place against the virus, the federal government asked security agencies not to cut corners, addi...
